RUBINO, TIZIANA
 Distribuzione geografica
Continente #
NA - Nord America 9.348
EU - Europa 5.868
AS - Asia 1.197
SA - Sud America 99
Continente sconosciuto - Info sul continente non disponibili 11
AF - Africa 10
OC - Oceania 3
Totale 16.536
Nazione #
US - Stati Uniti d'America 9.299
IT - Italia 3.167
UA - Ucraina 922
SE - Svezia 555
TR - Turchia 444
VN - Vietnam 280
CN - Cina 275
DE - Germania 244
FI - Finlandia 243
IE - Irlanda 240
GB - Regno Unito 166
SG - Singapore 137
RU - Federazione Russa 125
BR - Brasile 83
FR - Francia 72
CA - Canada 39
NL - Olanda 29
BE - Belgio 27
JP - Giappone 27
CZ - Repubblica Ceca 26
EU - Europa 11
CH - Svizzera 8
BG - Bulgaria 6
ES - Italia 6
CL - Cile 5
IN - India 5
AT - Austria 4
DK - Danimarca 4
HK - Hong Kong 4
HU - Ungheria 4
MX - Messico 4
AR - Argentina 3
KR - Corea 3
MA - Marocco 3
MD - Moldavia 3
MY - Malesia 3
NG - Nigeria 3
NO - Norvegia 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
CO - Colombia 2
DO - Repubblica Dominicana 2
IQ - Iraq 2
JO - Giordania 2
PA - Panama 2
PH - Filippine 2
PL - Polonia 2
PT - Portogallo 2
PY - Paraguay 2
SM - San Marino 2
VE - Venezuela 2
ZA - Sudafrica 2
AL - Albania 1
EC - Ecuador 1
EG - Egitto 1
GR - Grecia 1
HN - Honduras 1
ID - Indonesia 1
IL - Israele 1
IR - Iran 1
JM - Giamaica 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LI - Liechtenstein 1
LT - Lituania 1
LU - Lussemburgo 1
MM - Myanmar 1
MN - Mongolia 1
MT - Malta 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
TW - Taiwan 1
UY - Uruguay 1
Totale 16.536
Città #
Milan 2.012
Fairfield 1.355
Woodbridge 851
Chandler 755
Ashburn 718
Jacksonville 709
Houston 665
Seattle 583
Ann Arbor 534
Wilmington 510
Cambridge 467
Dearborn 272
Princeton 257
Nyköping 248
Dublin 239
Izmir 222
Como 176
Boardman 170
Rome 157
Dong Ket 142
Singapore 118
New York 107
San Mateo 93
San Diego 71
Chicago 58
Beijing 44
Ogden 44
Washington 38
London 34
Norwalk 30
Santa Clara 30
Toronto 30
Helsinki 29
Hefei 27
Los Angeles 27
Munich 27
Tokyo 26
Brussels 25
Brno 24
Kunming 22
Ponte Lambro 22
Nanjing 21
Verona 18
Mcallen 17
Kocaeli 15
Carbonara Al Ticino 14
Nanchang 14
Berlin 13
Redwood City 12
Varese 12
Guangzhou 11
Jinan 11
Naples 10
Düsseldorf 9
Dallas 8
Frankfurt am Main 8
Istanbul 8
Ottawa 8
Redmond 8
Shanghai 8
São Paulo 8
Auburn Hills 7
Bologna 7
Cagliari 7
Cairate 7
Edinburgh 7
Falls Church 7
Fuzhou 7
Gallarate 7
Gavirate 7
Palermo 7
Amsterdam 6
Chongqing 6
Council Bluffs 6
Phoenix 6
Salerno 6
Turin 6
Ankara 5
Kilburn 5
Lappeenranta 5
Marnate 5
Oristano 5
Prescot 5
Shenyang 5
Sofia 5
Wandsworth 5
Benevento 4
Bollate 4
Borgomanero 4
Chengdu 4
Chiswick 4
Hounslow 4
Paris 4
Perugia 4
San Giuliano Milanese 4
Segrate 4
Southwark 4
Stockholm 4
Stuttgart 4
Zhengzhou 4
Totale 12.408
Nome #
Cannabinoidi ed ansia: meccanismi cellulari/molecolari e ruolo degli endocannabinoidi nella modulazione degli stati ansiosi 266
Adolescent exposure to THC in female rats disrupts developmental changes in the prefrontal cortex 258
Cannabidiol, a Non-Psychoactive Cannabinoid Compound, Inhibits Proliferation and Invasion in U87-MG and T98G Glioma Cells through a Multitarget Effect 231
Alterations of prefrontal cortex GABAergic transmission in the complex psychotic-like phenotype induced by adolescent delta-9-tetrahydrocannabinol exposure in rats 219
Correlati cellulari e molecolari dell'abuso di Salvia divinorum: ruolo dei recettori cannabici e k oppioidi 216
Bidirectional regulation of mu-opioid and CB1-cannabinoid receptor in rats self-administering heroin or WIN 55,212-2 209
The Depressive Phenotype Induced in Adult Female Rats by Adolescent Exposure to THC is Associated with Cognitive Impairment and Altered Neuroplasticity in the Prefrontal Cortex 201
Assay of GTPγS binding in autoradiography 200
Adolescent THC exposure in female rats leads to cognitive deficits through a mechanism involving chromatin modifications in the prefrontal cortex 200
Binding of Δ9-tetrahydrocannabinol and diazepam to human serum albumin 198
Adolescent exposure to cannabis as a risk factor for psychiatric disorders 196
CB1 receptor stimulation in specific brain areas differently modulate anxiety-related behaviour 195
Cannabidivarin completely rescues cognitive deficits and delays neurological and motor defects in male Mecp2 mutant mice 194
Long lasting consequences of cannabis exposure in adolescence. 191
Cannabinoid CB1 receptor antagonism prevents neurochemical and behavioural deficits induced by chronic phencyclidine 191
Cannabis abuse in adolescence and the risk of psychosis: A brief review of the preclinical evidence. 191
Transcriptomic and Proteomic Analyses of Mouse Cerebellum Reveals Alterations in RasGRF1 Expression Following In Vivo Chronic Treatment with Delta 9-Tetrahydrocannabinol. 190
New vistas on cannabis use disorder 188
Long-term hippocampal glutamate synapse and astrocyte dysfunctions underlying the altered phenotype induced by adolescent THC treatment in male rats. 186
Role in anxiety behavior of the endocannabinoid system in the prefrontal cortex 184
A molecular basis of analgesic tolerance to cannabinoids 182
Cannabidiol inhibits human glioma cell migration through a cannabinoid receptor-independent mechanism 176
Cannabinoids and opioids share cAMP pathway in rat splenocytes 175
Endocannabinoids and Mental Disorders. 172
The anabolic steroid nandrolone alters cannabinoid self-administration and brain CB1 receptor density and function 164
Role of endocannabinoids in regulating drug dependence 163
Adult Cellular Neuroadaptations Induced by Adolescent THC Exposure in Female Rats Are Rescued by Enhancing Anandamide Signaling 162
Chronic FAAH inhibition during nicotine abstinence alters habenular CB1 receptor activity and precipitates depressive-like behaviors. 161
CANNABIDIOL/PHYTOCANNABINOIDS: A NEW OPPORTUNITY FOR SCHIZOPHRENIA TREATMENT? 160
Changes in endocannabinoid levels in a rat model of behavioural sensitization to morphine 158
Chronic treatment with polychlorinated biphenyls (PCB) during pregnancy and lactation in the rat Part 1: Effects on somatic growth, growth hormone-axis activity and bone mass in the offspring 158
Cannabinoids and Drugs of abuse 157
Neurobiological alterations at adult age triggered by adolescent exposure to cannabinoids. 157
Chronic URB597 treatment at adulthood reverted most depressive-like symptoms induced by adolescent exposure to THC in female rats. 156
Modulation of rat brain cannabinoid receptors after chronic morphine treatment 155
The endocannabinoid system and schizophrenia: integration of evidence. 155
Chronic Delta(9)-THC Exposure Differently Affects Histone Modifications in the Adolescent and Adult Rat Brain 155
Mice heterozygous for the oxytocin receptor gene (Oxtr(+/-) ) show impaired social behaviour but not increased aggression or cognitive inflexibility: evidence of a selective haploinsufficiency gene effect. 154
Comparative analysis of molecular strategies attenuating positional effects in lentiviral vectors carrying multiple genes 152
Remote memories are enhanced by COMT activity through dysregulation of the endocannabinoid system in the prefrontal cortex 150
Sex-dependent vulnerability to cannabis abuse in adolescence 149
Cannabidivarin Treatment Ameliorates Autism-Like Behaviors and Restores Hippocampal Endocannabinoid System and Glia Alterations Induced by Prenatal Valproic Acid Exposure in Rats 148
Molecular and cellular basis of cannabinoid and opioid interactions 147
Changes in hippocampal morphology and neuroplasticity induced by adolescent THC treatment are associated with cognitive impairment in adulthood 146
SK channel modulation rescues striatal plasticity and control over habit in cannabinoid tolerance. 145
Cellular mechanisms underlying the interaction between cannabinoid and opioid system 143
Gender-dependent behavioral and biochemical effects of adolescent delta-9-tetrahydrocannabinol in adult maternally deprived rats. 142
Endocannabinoids and Drug Dependence 141
Involvement of the endocannabinoid system in phencyclidine-induced cognitive deficits modelling schizophrenia. 140
Endocannabinoids in the immune system and cancer 137
Molecular mechanisms involved in the asymmetric interaction between cannabinoid and opioid systems 137
The psychoactive ingredient of marijuana induces behavioural sensitization 136
Differential diurnal variations of anandamide and 2-arachidonoyl-glycerol levels in rat brain 136
Adolescent cannabis use and psychosis: epidemiology and neurodevelopmental models 136
In vivo characterization of the specific cannabinoid receptor antagonist, SR 141716A: behavioral and cellular responses after acute and chronic treatments 135
Changes in the cannabinoid receptor binding, G protein coupling, and cyclic AMP cascade in the CNS of rats tolerant to and dependent on the synthetic cannabinoid compound CP55,940 134
Ras/ERK signalling in cannabinoid tolerance: from behaviour to cellular aspects 134
The endocannabinoid system and psychiatric disorders. 134
null 132
Chronic morphine modulates the contents of the endocannabinoid, 2-arachidonoyl glycerol, in rat brain 131
Changes in the expression of G protein-coupled receptor kinases and beta-arrestins in mouse brain during cannabinoid tolerance - A role for Ras-ERK cascade 128
Long-lasting recovery of psychotic-like symptoms in isolation-reared rats after chronic but not acute treatment with the cannabinoid antagonist AM251. 128
Pharmacologic rescue of impaired cognitive flexibility, social deficits, increased aggression, and seizure susceptibility in oxytocin receptor null mice: a neurobehavioral model of autism. 125
Neurobiological mechanisms underlying cannabis-induced memory impairment 125
Sex-dependent changes in brain CB1R expression and functionality and immune CB2R expression as a consequence of maternal deprivation and adolescent cocaine exposure 124
Cannabinoids inhibit nitric oxide production in bone marrow derived feline macrophages 123
Cellular Mechanisms Underlying The Anxiolytic Effect Of Low Doses Of Peripheral D9-Tetrahydrocannabinol In Rats 123
Susceptibility to Psychiatric Diseases After Cannabis Abuse in Adolescence: Animal Models 123
Presence of a reduced opioid response in interleukin-6 knock out mice 122
Long-term consequences of URB597 administration during adolescence on cannabinoid CB1 receptor binding in brain areas. 122
Estrogenic effect of procymidone through activation of MAPK in MCF-7 breast carcinoma cell line 118
Lifelong imbalanced linoleic/alpha-linolenic acid intake impairs emotional and cognitive behavior in adult rats via changes in brain endocannabinoid system 118
The Impact of Exposure to Cannabinoids in Adolescence: Insights from Animal Models 115
Changes in rat spleen cannabinoid receptors after chronic CP-55,940: an autoradiographic study. 114
Cellular mechanisms of Delta(9)-tetrahydrocannabinol behavioural sensitization 113
Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors 113
Further investigations on the antipropulsive effect of centrally administered histamine and its relation with morphine. 113
Modulation of extracellular signal-regulated kinases cascade by cronic Delta(99-tetrahydrocannabinol treatment 113
Sexually dimorphic effects of cannabinoid compounds on emotion and cognition. 112
Is cannabinoid transmission involved in rewarding properties of drugs of abuse 110
Chronic delta 9-tetrahydrocannabinol during adolescence provokes sex-dependent changes in the emotional profile in adult rats: behavioral and biochemical correlates. 110
Pertussis toxin modifies the effect of central morphine on rat intestinal motility. 107
Chronic nandrolone decanoate exposure during adolescence affects emotional behavior and monoaminergic neurotransmission in adulthood 105
Pertussis toxin pretreatment affects opiate/nonopiate and stress-induced analgesia differently. 103
Uso di Cannabis in adolescenza come fattore di rischio per malattie psichiatriche e dipendenza da altre sostanze 103
Termination of acute stress response by the endocannabinoid system is regulated through LSD1-mediated transcriptional repression of 2-AG hydrolases ABHD6 and MAGL 101
Studio sperimentale dell'interazione tra abuso di steroidi anabolizzanti e cannabinoidi nella depressione: dall'analisi comportamentale ai substrati cellulari 99
Cholera toxin antagonizes morphine-induced catalepsy through a cyclic AMP-independent mechanism. 99
Il sistema endocannabinoide 98
ERK-dependent modulation of cerebellar synaptic plasticity after chronic Delta 9-tetrahydrocannabinol exposure 96
Cannabinoid-precipitated withdrawal: a time-course study of the behavioral aspect and its correlation with cannabinoid receptors and G protein expression. 95
Ruolo emergente dei meccanismi epigenetici e della neuroinfiammazione nei disturbi associate al consume di cannabis 94
Presence of a reduced opioid response in interleukin-6 knock out mice. 93
The role of the endogenous cannabinoid system in drug addiction. 92
Bombesin receptor antagonist. 2. Analogues based on substance P antagonists 92
CB1 cannabinoid and mu opioid receptors density and functionality are altered in rats self-administering either heroin or the CB1 receptor agonist WIN 55,212-2 91
PLOS One 91
Effect of chronic exposure to naltrexone and opioid selective agonists on G protein mRNA levels in the rat nervous system. 89
Behavioral, proteomic and lipidomic analyses in adult male and female rats exposed to cannabinoids during adolescence: an integrative approach to identify markers of vulnerability for psychiatric disorders and drug abuse 87
Intestinal effect of morphine 6-glucuronide: in vivo and in vitro characterization. 86
Totale 14.422
Categoria #
all - tutte 62.975
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 62.975


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.172 0 0 0 0 0 0 0 401 286 229 66 190
2020/20212.349 67 229 102 202 156 263 122 167 341 139 229 332
2021/20221.413 144 162 114 183 52 61 61 73 59 209 121 174
2022/20231.951 188 132 123 257 97 417 2 272 249 72 107 35
2023/20243.372 505 534 514 580 623 302 17 69 70 53 36 69
2024/2025953 43 47 356 91 70 160 112 74 0 0 0 0
Totale 16.687